发明名称 |
TREATMENT OF MULTIPLE SCLEROSIS USING COP-1 AND Th2-ENHANCING CYTOKINES |
摘要 |
The invention relates to a treatment for multiple sclerosis. COP-1 (copolymer-1), a synthetic polymer consisting of a mixture of random synthetic polypeptides composed of L-alanin, L-glutamic acid, L-lysine and L-tyrosine in a molar ratio of about 6:2:5:1, is administered mucosally to patients afflicted with the disease in combination with Th2 enhancing cytokines such as IL-4 or IL-10. The combination treatment of IL-4 of IL-10 (preferably orally administered) with mucosally administered COP-1 shows a substantially greater suppressive effect than does treatment with cytokine or COP-1 alone.
|
申请公布号 |
WO9941247(A1) |
申请公布日期 |
1999.08.19 |
申请号 |
WO1999US03308 |
申请日期 |
1999.02.12 |
申请人 |
AUTOIMMUNE, INC.;WEINER, HOWARD, L.;MARRON, RUTH;SLAVIN, ANTHONY |
发明人 |
WEINER, HOWARD, L.;MARRON, RUTH;SLAVIN, ANTHONY |
分类号 |
A61K9/20;A61K9/48;A61K38/00;A61K38/20;A61P25/00;A61P37/06;(IPC1-7):C07D307/91;A61K31/34;A61K38/19 |
主分类号 |
A61K9/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|